Table 2.
SSRI (n = 19) | SNRI (n = 18) | NDRI (n = 11) | NaSSA (n = 4) | Agomelatine (n = 9) | Significance | |
---|---|---|---|---|---|---|
C-reactive protein (CRP) (pg/ml) | 2322.6 ± 3028.6 | 999.8 ± 1408.8 | 3133.2 ± 2206.4 | 978.3 ± 605.4 | 1366.4 ± 1930.0 | n.s. |
Soluble interleukin-2 receptor (sIL-2R) (pg/ml) | 643.7 ± 211.2 | 611.5 ± 177.7 | 851.0 ± 358.3 | 825.1 ± 316.8 | 561.7 ± 220.8 | n.s. |
Soluble interleukin-6 receptor (sIL-6R) (pg/ml) | 29,504.2 ± 5970.7 | 28,075.4 ± 9047.5 | 29,518.2 ± 9497.3 | 35,502.9 ± 8097.8 | 28,205.8 ± 11,328.8 | n.s. |
Soluble tumor necrosis factor receptor type 1 (sTNF-R1) (pg/ml) | 774.7 ± 134.7 | 753.1 ± 147.2 | 779.0 ± 235.0 | 863.9 ± 583.3 | 653.0 ± 181.7 | n.s. |
NaSSA noradrenergic and specific serotonergic antidepressant, NDRI norepinephrine dopamine reuptake inhibitor, SNRI serotonin-norepinephrine reuptake inhibitor, SSRI selective serotonin reuptake inhibitor, n.s. not significant